{"id":2536,"date":"2019-04-03T17:50:32","date_gmt":"2019-04-03T15:50:32","guid":{"rendered":"https:\/\/biologika-register.de\/?page_id=2536"},"modified":"2019-04-03T17:57:39","modified_gmt":"2019-04-03T15:57:39","slug":"sections","status":"publish","type":"page","link":"https:\/\/biologika-register.de\/en\/rabbit\/informationen-zur-studie-fuer-aerzte-2\/einschlusskriterien\/sections\/","title":{"rendered":"Sections"},"content":{"rendered":"

sdfgsdfgsd
\nsfg\n\n\n\n\t\n\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t
Biosimilar<\/th>\n<\/tr>\n<\/thead>\n
Amgevita\u00ae (Adalimumab)<\/td>\n<\/tr>\n
Benepali\u00ae (Etanercept)<\/td>\n<\/tr>\n
Erelzi\u00ae (Etanercept)<\/td>\n<\/tr>\n
Flixabi\u00ae (Infliximab)<\/td>\n<\/tr>\n
Hukyndra\u00ae (Adalimumab)<\/td>\n<\/tr>\n
Hulio\u00ae (Adalimumab)<\/td>\n<\/tr>\n
Hyrimoz\u00ae (Adalimumab)<\/td>\n<\/tr>\n
Idacio\u00ae (Adalimumab)<\/td>\n<\/tr>\n
Imraldi\u00ae (Adalimumab)<\/td>\n<\/tr>\n
Inflectra\u00ae (Infliximab)<\/td>\n<\/tr>\n
Nepexto\u00ae (Etanercept)<\/td>\n<\/tr>\n
Remsima\u00ae (Infliximab)<\/td>\n<\/tr>\n
Rixathon\u00ae (Rituximab)<\/td>\n<\/tr>\n
Ruxience\u00ae (Rituximab)<\/td>\n<\/tr>\n
Truxima\u00ae (Rituximab)<\/td>\n<\/tr>\n
Tyenne\u00ae (Tocilizumab)<\/td>\n<\/tr>\n
Yuflyma\u00ae (Adalimumab)<\/td>\n<\/tr>\n
Zessly\u00ae (Infliximab)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n\n\n\n\t\n\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t
Biologika<\/th>\n<\/tr>\n<\/thead>\n
Cimzia\u00ae (Certolizumab Pegol)<\/td>\n<\/tr>\n
Enbrel\u00ae (Etanercept)<\/td>\n<\/tr>\n
Humira\u00ae (Adalimumab)<\/td>\n<\/tr>\n
Kevzara\u00ae (Sarilumab )<\/td>\n<\/tr>\n
MabThera\u00ae (Rituximab)<\/td>\n<\/tr>\n
Orencia\u00ae (Abatacept)<\/td>\n<\/tr>\n
Remicade\u00ae (Infliximab)<\/td>\n<\/tr>\n
RoActemra\u00ae (Tocilizumab)<\/td>\n<\/tr>\n
Simponi\u00ae (Golimumab)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n\n\n\n\t\n\n\t\n\t\n\t\n\t
Kinase-\/ JAK -Inhibitoren <\/th>\n<\/tr>\n<\/thead>\n
Jyseleca\u00ae (Filgotinib)<\/td>\n<\/tr>\n
Olumiant\u00ae (Baricitinib)<\/td>\n<\/tr>\n
Rinvoq\u00ae (Upadacitinib)<\/td>\n<\/tr>\n
Xeljanz\u00ae (Tofacitinib)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n","protected":false},"excerpt":{"rendered":"

sdfgsdfgsd sfg<\/p>\n","protected":false},"author":7,"featured_media":0,"parent":277,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_crdt_document":"","generate_page_header":"","footnotes":""},"class_list":{"0":"post-2536","1":"page","2":"type-page","3":"status-publish","5":"infinite-scroll-item"},"_links":{"self":[{"href":"https:\/\/biologika-register.de\/en\/wp-json\/wp\/v2\/pages\/2536","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/biologika-register.de\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/biologika-register.de\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/biologika-register.de\/en\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/biologika-register.de\/en\/wp-json\/wp\/v2\/comments?post=2536"}],"version-history":[{"count":4,"href":"https:\/\/biologika-register.de\/en\/wp-json\/wp\/v2\/pages\/2536\/revisions"}],"predecessor-version":[{"id":2540,"href":"https:\/\/biologika-register.de\/en\/wp-json\/wp\/v2\/pages\/2536\/revisions\/2540"}],"up":[{"embeddable":true,"href":"https:\/\/biologika-register.de\/en\/wp-json\/wp\/v2\/pages\/277"}],"wp:attachment":[{"href":"https:\/\/biologika-register.de\/en\/wp-json\/wp\/v2\/media?parent=2536"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}